Epinephrine is the first-line treatment for severe allergic reactions, but far too often, people do not use or get it when needed. The FDA’s recent approval of neffy®, an epinephrine nasal spray , is a huge breakthrough. The allergy community now has a treatment option for severe and potentially life-threatening allergic reactions that does not use a needle. “An epinephrine nasal spray like neffy offers a new treatment option for people with anaphylaxis,“ said Kenneth Mendez, President and…
Quelle: Asthma and Allergy Foundation of America
Titelbild/Grafik: Asthma and Allergy Foundation of America (AAFA)
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Quick-Links
Aktuelles von Asthma and Allergy Foundation of America
- Access for All: Health Care Matters for Asthma and Allergies
- Know the Facts About Asthma and Allergies
- Advocacy in Action for Asthma and Allergy Awareness Month
- Honor Hezzy. Raise Awareness. Make a Difference.
- National Asthma and Allergy Awareness Month 2025: Let’s Make Asthma and Allergy Treatments Accessible for All!
- Pollen Counts, Forecasts, and Seasonal Allergies
- Food Allergen Labeling in Restaurants (Video)
- Resources to Help You Manage Nasal Polyps
- April Research Update: Asthma Clinical Trials, Insect Sting Allergy, Topical Steroid Withdrawal
- The CDC Asthma Program Is Gone
